Zelira Therapeutics (AU:ZLD) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Zelira Therapeutics has announced its Annual General Meeting (AGM) to be held on 14 November 2024, with the agenda including the adoption of financial reports, auditor appointments, and resolutions on director re-elections and share issuance capacities. The meeting will be accessible both online and at the company’s Perth location. Shareholder participation is critical as decisions made will impact shareholding and the company’s governance.
For further insights into AU:ZLD stock, check out TipRanks’ Stock Analysis page.
